The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blinded, phase III study of icaritin versus huachashu as the first-line therapy in biomarker-enriched HBV-related advanced hepatocellular carcinoma with poor conditions: Interim analysis result.
 
Yan Sun
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Yabing Guo
No Relationships to Disclose
 
Ying Zhang
No Relationships to Disclose
 
Lingzhan Meng
No Relationships to Disclose
 
Yuping Sun
No Relationships to Disclose
 
Hongbo Ji
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Xiufeng Liu
No Relationships to Disclose
 
Bin Hu
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Yi Li
No Relationships to Disclose
 
Zhiqiang Meng
No Relationships to Disclose
 
Kangsheng Gu
No Relationships to Disclose
 
Hong Guo
Employment - Beijing Shenogen Pharma
Stock and Other Ownership Interests - Beijing Shenogen Pharma
Travel, Accommodations, Expenses - Beijing Shenogen Pharma
 
Gang Chen
Stock and Other Ownership Interests - RG Pharma
Consulting or Advisory Role - Beijing Shenogen Biomedical
 
Bin Ye
Employment - Beijing Shenogen pharma
Stock and Other Ownership Interests - Beijing Shenogen Pharma
Travel, Accommodations, Expenses - Beijing Shenogen Pharma
 
Kun Meng
Employment - Beijing Shenogen Pharma
Leadership - Beijing Shenogen pharma
Stock and Other Ownership Interests - Beijing Shenogen Pharma
Travel, Accommodations, Expenses - Beijing Shenogen Pharma